The LifeSaver Project Is Finding Solutions to Fetal and Maternal Safety With In Vitro And In Silico Techniques.
An EU Funded Project:
Giving Babies a Healthier Start
One aim of the LifeSaver Project is to reduce neonatal and infant death rates in Europe. Across Europe about 75% of all neonatal deaths and 60% of all infant deaths occur in infants born preterm, and worldwide 450 neonatal deaths occur every hour. The number of preterm births is growing despite advances in medicine as more pregnancies are in the later age but also due to increasing environmental threats and lack of suitable treatments.
In the LifeSaver vision, every pregnant woman must have a proper living environment with minimal risks to the fetus, safeguarded with scientifically justified regulations in use and control of potentially risky chemical and medicinal products, leading to healthier quality lives of the babies, overarching for generations.
In Vitro System
LifeSaver concept is based on the hybridization of several innovative technologies, integrating digital in silico/in vitro (biodigital twin) systems. This enables the effective screening of chemicals and pharmaceuticals which might affect the health of pregnant women, and reduces animal, preclinical and clinical testing, which is not possible with other existing approaches to the same level of confidence.
A proper living environment with minimal risks to the fetus
Every woman safeguarded with scientifically justified regulations of potentially harmful chemical and medicinal products.